In this prospective study we assess the predictive ability of B-type natriuretic peptide (BNP) and lactate for complications after anatomic lung rescection. C34
Conditions
Interventions
Group 1: Patients undergoing anatomic lung resection including pneumonectomy, lobectomy, Bi-lobectomy and segmentectomy.
Serum BNP is measured at three different time points: preoperatively, shortly
Sponsors
Abteilung für Thoraxchirurgie,Klinik Schillerhöhe,Robert-Bosch-KrankenhausProf. Dr. med. Godehard Friedel, Dr. med. Ruoyu Zhang
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with confirmed or suspected lung cancer, who undergo anatomic lung resektion (pneumonectomy, lobectomy, Bi-lobectomy or segmentectomy) as elective surgery.
Exclusion criteria
Exclusion criteria: 1. Lack of willingness to participate or capacity for consent, 2. Urgent or emergency surgery, 3. Redo surgery, 4. Age < 18, 5. Angina pectoris, myocardial infarction, pulmonary oedema, stroke or pneumonia in the last months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the cardiopulmonary complication 6 months following anatomic lung resection. Patient follow-up is carried out 6 weeks and 6 months following anatomic lung resection in the out-patient department. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome is the overall morbidity 6 months following anatomic lung resection. Patient follow-up is carried out 6 weeks and 6 months following anatomic lung resection in the out-patient department. | — |
Countries
Germany
Contacts
Public ContactRuoyu Zhang
Abteilung für ThoraxchirurgieKlinik Schillerhöhe, Robert-Bosch-Krankenhaus
Outcome results
None listed